Outcomes after discontinuing immunotherapy for allergic fungal sinusitis

Otolaryngology - Head and Neck Surgery

Volumn 122, Issue 1, 2000, Pages 104-106

  Mabry, Richard L ^a   Marple, Bradley F ^a   Mabry, Cynthia S ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT;

ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; FOLLOW UP; HUMAN; IMMUNOTHERAPY; MYCOSIS; TREATMENT OUTCOME;

EID: 0033976582     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0194-5998(00)70153-7     Document Type: Article

References (7)

1. RL Mabry SC Manning CS Mabry Immunotherapy in the treatment of allergic fungal sinusitis Otolaryngol Head Neck Surg 116 1997 31 35
2. RL Mabry CS Mabry Immunotherapy for allergic fungal sinusitis: the second year Otolaryngol Head Neck Surg 117 1997 367 371
3. RL Mabry BF Marple RJ Folker Immunotherapy for allergic fungal sinusitis: three years’ experience Otolaryngol Head Neck Surg 119 1998 648 651
4. RJ Folker BF Marple RL Mabry Treatment of allergic fungal sinusitis: a comparison trial of postoperative immunotherapy with specific fungal antigens Laryngoscope 108 1998 1623 1627
5. RM Naclerio D Proud R Moylan A double-blind study of the discontinuation of ragweed immunotherapy J Allergy Clin Immunol 100 1997 293 300
6. Y Ohashi Y Nakai S Kihara House dust mite–specific IgE, IgG1, and IgG4 antibodies in perennial rhinitis Ann Otol Rhinol Laryngol 96 1987 434 437
7. Y Ohashi Y Nakai A Tanaka Serologic study of the working mechanisms of immunotherapy for children with perennial allergic rhinitis Arch Otolaryngol Head Neck Surg 124 1998 1337 1346